UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

The Lancet (British edition), 1999-01, Vol.353 (9150), p.345-350

1999

Volltextzugriff (PDF)

Phase I Clinical and Pharmacokinetic Study of Oral S-1 in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2000-07, Vol.18 (14), p.2772-2779

2000

Volltextzugriff (PDF)

Recycling and recharge at Hasandağ stratovolcano, Central Anatolia: insights from plagioclase textures and zoning patterns

Contributions to mineralogy and petrology, 2022-08, Vol.177 (8), Article 84

2022

Volltextzugriff (PDF)

Phase I Trial with BMS-275183, a Novel Oral Taxane with Promising Antitumor Activity

Clinical cancer research, 2006-03, Vol.12 (6), p.1760-1767

2006

Volltextzugriff (PDF)

A Phase I Safety and Pharmacologic Study of a Twice Weekly Dosing Regimen of the Oral Taxane BMS-275183

Clinical cancer research, 2007-07, Vol.13 (13), p.3906-3912

2007

Volltextzugriff (PDF)

Post-delamination magmatism in south-central Anatolia

Lithos, 2021-10, Vol.398-399, p.106299, Article 106299

2021

Volltextzugriff (PDF)

Mapping the increasing sophistication of students' understandings of plate tectonics: A learning progressions approach

Journal of geoscience education, 2019-01, Vol.67 (1), p.83-96

2019

Volltextzugriff (PDF)

Abstract 3991: Standardization and optimization of circulating microRNA serum profiling in patients with cancer

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3991-3991

2015

Volltextzugriff (PDF)

T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

Cancer Immunology, Immunotherapy, 2013-02, Vol.62 (2), p.245-256

2013

Volltextzugriff (PDF)

Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab

Journal for immunotherapy of cancer, 2014-09, Vol.2 (1), p.31-31, Article 31

2014

Volltextzugriff (PDF)

Pharmacokinetics and Pharmacodynamics of Lobaplatin (D-19466) in Patients with Advanced Solid Tumors, Including Patients with Impaired Renal or Liver Function

Clinical cancer research, 1999-09, Vol.5 (9), p.2349-2358

1999

Volltextzugriff (PDF)

A Geochemical Approach to Mantle and Crustal Dynamics in Central Anatolia

Gall, Helen Deborah

2018

Volltextzugriff (PDF)

Modeling the mechanism of plate tectonics

Science scope (Washington, D.C.), 2018-09, Vol.42 (2), p.45-54

2018

Volltextzugriff (PDF)

Getting Beneath the Surface: Modeling the mechanism of plate tectonics

Science scope (Washington, D.C.), 2018-09, Vol.42 (2), p.45-54

2018

Volltextzugriff (PDF)

Getting Beneath the Surface

Science scope (Washington, D.C.), 2018-09, Vol.42 (2), p.45-54

2018

Volltextzugriff (PDF)

Getting beneath the surrace: Modeling the mechanism of plate tectonics

Science scope (Washington, D.C.), 2018-09, Vol.42 (2), p.45

2018

Volltextzugriff (PDF)

A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancer

Anti-cancer drugs, 2007-02, Vol.18 (2), p.219-225

2007

Volltextzugriff (PDF)

Abstract 5381: Activation and frequency of myeloid subsets in peripheral blood is associated with clinical outcome in prostate cancer patients treated with Prostate GVAX and anti-CTLA4

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5381-5381

2012

Volltextzugriff (PDF)

Abstract 1229: Pre-existing NY-ESO-1-specific T cell reactivity is associated with improved clinical outcome in castration resistant prostate cancer patients treated with Prostate GVAX and ipilimumab

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1229-1229

2013

Volltextzugriff (PDF)

Abstract 496: Inflammatory responses with infiltrating DC and functional cytotoxic T lymphocytes in the dermal vaccination sites of GVAX/ipilimumab treated prostate cancer patients

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.496-496

2013

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) cancer patients

Cancer research (Chicago, Ill.), 1986-09, Vol.46 (9), p.4831-4836

1986

Volltextzugriff (PDF)

T cell profiling reveals high CD4 super(+)CTLA-4 super(+) T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

Cancer Immunology, Immunotherapy, 2013-02, Vol.62 (2), p.245-256

2013

Volltextzugriff (PDF)

Measurement of workload in clinical trial

European journal of cancer (1990), 1997-09, Vol.33, p.S316-S317

Gall, Helen

1997

Volltextzugriff (PDF)

Abstract 5512: Immune correlates of clinical response and survival in castration-resistant prostate cancer patients treated with prostate GVAX and anti-CTLA4 immunotherapy

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5512-5512

2011

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(100)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(65)
Life Sciences & Biomedicine
(60)
Humans
(55)
Female
(35)
Male
(34)
Aged
(29)
Middle Aged
(28)
Adult
(24)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Oncology
(21)
Pharmacology. Drug Treatments
(15)
Antineoplastic Agents
(14)
Neoplasms - Drug Therapy
(13)
Antineoplastic Agents - Therapeutic Use
(10)
Neurosciences & Neurology
(10)
Chemotherapy
(9)
Stroke
(9)
Aged, 80 And Over
(7)
Clinical Neurology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

Phase I Clinical and Pharmacokinetic Study of Oral S-1 in Patients With Advanced Solid Tumors

Recycling and recharge at Hasandağ stratovolcano, Central Anatolia: insights from plagioclase textures and zoning patterns

Phase I Trial with BMS-275183, a Novel Oral Taxane with Promising Antitumor Activity

A Phase I Safety and Pharmacologic Study of a Twice Weekly Dosing Regimen of the Oral Taxane BMS-275183

Post-delamination magmatism in south-central Anatolia

Mapping the increasing sophistication of students' understandings of plate tectonics: A learning progressions approach

Abstract 3991: Standardization and optimization of circulating microRNA serum profiling in patients with cancer

T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab

Pharmacokinetics and Pharmacodynamics of Lobaplatin (D-19466) in Patients with Advanced Solid Tumors, Including Patients with Impaired Renal or Liver Function

A Geochemical Approach to Mantle and Crustal Dynamics in Central Anatolia

Modeling the mechanism of plate tectonics

Getting Beneath the Surface: Modeling the mechanism of plate tectonics

Getting Beneath the Surface

Getting beneath the surrace: Modeling the mechanism of plate tectonics

A phase I and pharmacokinetic study of LAF389 administered to patients with advanced cancer

Abstract 5381: Activation and frequency of myeloid subsets in peripheral blood is associated with clinical outcome in prostate cancer patients treated with Prostate GVAX and anti-CTLA4

Abstract 1229: Pre-existing NY-ESO-1-specific T cell reactivity is associated with improved clinical outcome in castration resistant prostate cancer patients treated with Prostate GVAX and ipilimumab

Abstract 496: Inflammatory responses with infiltrating DC and functional cytotoxic T lymphocytes in the dermal vaccination sites of GVAX/ipilimumab treated prostate cancer patients

Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) cancer patients

T cell profiling reveals high CD4 super(+)CTLA-4 super(+) T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment

Measurement of workload in clinical trial

Abstract 5512: Immune correlates of clinical response and survival in castration-resistant prostate cancer patients treated with prostate GVAX and anti-CTLA4 immunotherapy

Suchergebnisse filtern